NOTE: I am a paid consultant to Nyxoah, reviewing preoperative drug-induced sleep endoscopy videos. I have no access to any data regarding treatment outcomes. The just-concluded 2024 Miami International Surgical Sleep Society meeting included presentation of long-awaited trials from Nyxoah’s DREAM study and a number of other important presentations for the field of sleep surgery…. Read more »

DISCLAIMER: I am a consultant for Nyxoah, who manufactures a technology mentioned in this blog post. Inspire Medical Systems’ Upper Airway Stimulation is the only FDA-approved treatment of obstructive sleep apnea based on stimulation of the nerve that controls tongue movement (hypoglossal nerve). Based on their successes, a number of other technologies are in clinical… Read more »

The last thing anyone wants is to undergo surgery without achieving results. This idea has been the focus of my career in sleep surgery. It has been wonderful to contribute to advancing our understanding about the physical causes of obstructive sleep apnea and ways we can optimize our preoperative evaluation to select procedures. This work… Read more »

Nashville, TN was the site of both the 2023 International Surgical Sleep Society (ISSS) Educational Symposium and American Academy of Otolaryngology – Head and Neck Surgery Foundation Annual Meeting. It is always wonderful to see colleagues and long-time friends. However, I wanted to take the chance to share some of what I found to be… Read more »

Since its FDA approval in 2014, the Upper Airway Stimulation system from Inspire Medical Systems has dominated the landscape of nerve stimulation in the treatment of obstructive sleep apnea. A number of companies have been involved in development of hypoglossal nerve stimulation technologies, and this month one of those companies (LivaNova) had publication of results… Read more »

Surgery for obstructive sleep apnea often involves surgery of the throat that removes, repositions, and/or tightens tissue. Although the goal is to improve or eliminate the sleep apnea, the risks include the potential to disrupt normal function, especially speech and swallowing. Fortunately, speech changes have always been rare, but changes in swallowing have always been… Read more »

Drug-induced sleep endoscopy has demonstrated clearly that the epiglottis can play an important role in obstructive sleep apnea in about 5-10% of patients. Surgical treatment approaches suggest that that treatment of the epiglottis specifically can provide substantial improvement in these cases. Multiple procedures have been proposed as options in cases of epiglottis-related obstruction; two of… Read more »

We have just completed the 27th Annual Advances in Diagnosis and Treatment of Sleep Apnea and Snoring course in San Francisco, California. It has been wonderful to be a co-director for about 15 years, and I learn so much myself in every course. This year we did something different: a virtual format! We can thank… Read more »

Like most surgical treatments throughout medicine, research studies typically evaluate short-term outcomes. In sleep surgery, most studies report results at 3-6 months following surgery. There are notable exceptions – including 5-year outcomes reported for Inspire Upper Airway Stimulation in the STAR Trial presented at the Sleep 2017 meeting and then published in the medical journal… Read more »

Well-done randomized trials offer the highest-quality scientific evaluation of any medical intervention. Unfortunately, randomized trials of surgical interventions are extremely difficult to perform, for numerous reasons. In sleep surgery, there have been a number of randomized trials showing that surgical treatment of obstructive sleep apnea can offer important benefits that matter to patients. These include… Read more »